Biogen Announces Agreement to Acquire Nightstar Therapeutics to Establish Clinical Pipeline of Gene Therapy Candidates in Ophthalmology Read more
Exclusive speaker interview released with Sumitomo Rubber ahead of Pre-filled Syringes West Coast 2019 Read more
NantKwest Signs Worldwide License Agreement with ProMab Biotechnologies to Exclusively Develop Select Next Generation Targeted Natural Killer Cell Therapeutics Read more
Industry experts to discuss containment solutions and ADC developments at Highly Potent Active Pharmaceutical Ingredients (HPAPI) 2019 Read more
Apellis Announces Collaboration with SFJ Pharmaceuticals for APL-2 in Hematologic Indications Read more
FDA approves Herceptin Hylecta for subcutaneous injection in certain HER2-positive breast cancers Read more
Maze Therapeutics Launches with $191 Million to Focus on Translating Genetic Insights into New Medicines Read more
AbCellera and Denali Sign Expanded Multi-Year, Multi-Target Deal to Discover Therapeutic Antibodies for Neurological Diseases Read more